Note: This grant page has been archived and is very likely out of date.

Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Suggest an update

Deadline: The deadline for this grant has passed

Grant amount: Up to US $10,000,000

Fields of work: Infectious & Parasitic Diseases Respiratory Diseases & Systems

Applicant type: Organizations

Funding uses: Non-clinical Biomedical

Location of project: Anywhere in the world

Location of residency: United States


NOTE: Applications must be submitted by 5 p.m. submitter's local time. 

The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.

The goal of this initiative is to solicit applications for the development of novel, non-traditional approaches to identify the current SARS-CoV-2 virus or other biomarkers of the COVID-19 disease for use in outbreaks of COVID-19, as well as for use in future pandemics resulting from new and emerging viruses. Specifically, this FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e., scents or odors) emanating from skin or exhaled breath, saliva and different oral tissues from the oral cavity. These sensing devices must be able to associate VOC patterns to patients with symptomatic and asymptomatic COVID-19.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

This page was last reviewed August 24, 2020 and last updated August 24, 2020